Table 3.
Analysis of influencing factors of endoscopic therapy
Factor | Endoscopic treatment success group |
Endoscopic treatment failure group |
χ2/t | P value |
Cause | ||||
Post-hepatitis B/C cirrhosis group | 34 | 9 | ||
Alcoholic cirrhosis group | 5 | 3 | ||
Autoimmune hepatitis group | 3 | 2 | ||
Other | 3 | 1 | χ2=1.647 | p=0.649 |
Degree of varicose veins | ||||
Severe | 28 | 14 | ||
Moderate | 17 | 1 | χ2=5.185 | p=0.023 |
Bleeding location | ||||
Middle esophagus | 7 | 1 | ||
Lower esophagus | 27 | 7 | ||
Cardia | 8 | 5 | ||
Fundus | 2 | 2 | χ2=3.210 | p=0.360 |
Treatment | ||||
EVL Treatment | 31 | 9 | ||
Tissue glue injection | 14 | 6 | χ2=0.400 | p=0.527 |
Coinfection | 21 | 12 | ||
No co-infection | 24 | 3 | χ2=5.051 | p=0.025 |
With ascites | 30 | 14 | ||
No ascites | 15 | 1 | χ2=4.091 | p=0.043 |
Portal vein thrombosis or tumor thrombus | 14 | 10 | ||
No portal vein thrombosis or tumor thrombus | 31 | 5 | χ2=5.926 | p=0.015 |
Blood index | ||||
Median (lower quartile, upper quartile) | ||||
Albumin | 31.0 (28.0,33.5) | 27.0 (25.0,29.0) | z =-2.455 | p=0.014 |
Platelet count | 78.0 (50.0,103) | 68.0 (66.0,101.0) | z =-0.572 | p=0.567 |
Prothrombin activity | 63.0 (55.5,81.5) | 44..0 (38.0,64.0) | z =-2.486 | p=0.013 |
Child Pugh | ||||
Class A | 21 | 2 | ||
Class B | 12 | 3 | ||
Class C | 12 | 10 | χ2=8.370 | p=0.015 |